Higher concentrations mean fewer units for the same dose
For example, the Rotterdam criteria permit a phenotype defined by ovulatory dysfunction and PCOM in the absence of hyperandrogenism, whereas the NIH criteria require hyperandrogenism together with ovulatory dysfunction
Phase 2 trial data showed a mean body weight reduction of approximately 24% at the highest dose (12 mg) over 48 weeks, though Phase 3 confirmation is required
In the OASIS-4 trial, the once-daily 25 mg tablet produced an average weight loss of 13.6% over 64 weeks among all participants who started the trial
Month 6+: Healthy Weight Management Participants in a clinical study using Morosil red orange extract showed a reduction in body weight, reduction in visceral fat and a reduction in hip and waist circumference, in combination with healthy diet and exercise
For readers interested in related wellness strategies, visit our top articles on Health.HealingWell.com